The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via

The United States has approved an emergency humanitarian waiver allowing continued access to HIV treatment funded by the U.S. across 55 countries worldwide including Kenya. On January 29, 2025, U.S. Secretary of State Marco Rubio authorized the waiver,

The President's Emergency Plan for AIDS Relief has provided life-saving treatment to tens of millions since it was established in 2003

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been stopped.

Millions at risk as funding for AIDS relief program halts, potentially disrupting antiviral medication provision.

The Trump administration on January 24 halted disbursement of funds to programmes to treat HIV, malaria and other diseases in developing countries for at least 90 days.

PEPFAR, a $7.5 billion initiative established in 2003, has provided HIV care to millions worldwide. The recent suspension of the program raised concerns about the potential loss of access to HIV medications for more than 20 million people.

Secretary of State Marco Rubio’s order to pause nearly all foreign aid has halted funding to the President’s Emergency Plan for AIDS Relief (PEPFAR), an African HIV-prevention program launched by President George W. Bush in 2003 that has saved over 25 million lives.

A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left organizations uncertain.

PEPFAR partners describe a whiplash-inducing stop-work order, which has left them with many questions — including whether they can continue to provide lifesaving treatment — but very few answers.

The President’s Emergency Program for AIDS Relief is in danger of shuttering. The decision could kill hundreds of thousands of people and kickstart an epidemic.